FDA Actions
News
FDA addresses cell-based regenerative medicine in comprehensive new policy
Clarifying the existing regulations will “promote responsible and flexible regulation that leverages science to advance public health,” according...
News from the FDA/CDC
FDA approves topical oxymetazoline for rosacea
A topical cream containing the vasoconstrictor oxymetazoline has been approved by the Food and Drug Administration to treat symptoms of rosacea,...
News from the FDA/CDC
FDA bans powdered gloves
The FDA has banned powdered gloves for use in health care settings, citing “numerous risks to patients and health care workers.”
Commentary
Absorb’s problems will revise coronary scaffold standards
Will the failure of Absorb to show benefits after 3 years in the ABSORB II trial dampen enthusiasm for the concept of a bioresorbable coronary...